CERC-501 - CAS# 1174130-61-0 size:10mg solid Samaniego F

Samaniego F

PubMed PMID: 19122279

including the premature-aging disease Hutchinson-Gilford progeria syndrome (HGPS)

a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor

Su-11274 increases tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation

CERC-501 - CAS# 1174130-61-0 size:10mg solid Samaniego FCERC 501, also known as JNJ 67953964, LY 2456302 and Aticaprant, CAS No. 1174130 61 0, is a potent, selective, short acting antagonist of the opioid receptor (KOR) (Ki = 0. 81 nM vs. 24. 0 nM and 155 nM for the opioid receptor (MOR) and opioid receptor (DOR). Aticaprant is under development for the treatment of major depressive disorder and substance use disorders including alcoholism, nicotine addiction, and illicit drug dependence. Aticaprant has